Clinical Trials Logo

Clinical Trial Summary

The distal ileum, where the glucagon-like peptide 1 (GLP-1) releasing cells predominate, is an important organ in mediating glycemic control. However, the distal ileum is not easy to access and the correspond in vivo research remains to be difficult. The investigators intend to recruit subjects who underwent rectal surgery with simultaneous protective ileostomy and evaluate hormone secretion and glycemic excursions via ileostomy glucose or saline infusion, and quantify the glucose absorption rate within the distal ileum.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05030376
Study type Interventional
Source Qilu Hospital of Shandong University
Status Not yet recruiting
Phase N/A
Start date September 1, 2021
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Terminated NCT04371978 - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 Phase 3
Not yet recruiting NCT03966261 - The Role of Incretins in Bone Remodeling in Humans